BIOBIS financials
A multi-period view of the public annual-account figures reported for BIOBIS, with comparable measures and links to available source documents.
Company overviewRegistry number
0657931697
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for BIOBIS
2025 versus 2024
- Operating line
- €21,175
- EBITDA
- €20,772
- Total assets
- €242,839
- Equity
- €241,029
+28.8%
+28.2%
+0.5%
+5.3%
EBITDA margin +98.1% · Equity ratio +99.3%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €21,175 | €20,772 | €242,839 | €241,029 | - |
| 202431 Dec 2024 | €16,436 | €16,201 | €241,693 | €229,000 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.